“Based on promising results in our first set of studies,
we will move the drug to the next phase and prepare
for clinic trials,” said Ning Yuan, Vice President Business Development at
Wanbang Biopharmaceuticals.
“We are very pleased with the results and the productive
collaboration with Sirona Biochem.”